# A Clinical Study of SHR-5421 in Patients With Multiple Myeloma

> **NCT07652281** · PHASE1 · RECRUITING · sponsor: **Suzhou Suncadia Biopharmaceuticals Co., Ltd.** · enrollment: 97 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** SHR-5421 for Injection

## Key facts

- **NCT ID:** NCT07652281
- **Lead sponsor:** Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-23
- **Primary completion:** 2028-04
- **Final completion:** 2029-04
- **Target enrollment:** 97 (ESTIMATED)
- **Last updated:** 2026-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07652281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07652281, "A Clinical Study of SHR-5421 in Patients With Multiple Myeloma". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07652281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*